Henry Schein, Inc.
|$10.7 B||Market Cap|
|6.7%||EBIT / EV|
|4.1%||FCF / EV|
|6.6%||3yr Avg Revenue Growth|
Business Model Diligence
We do not yet have Business Model Diligence for this stock.
|The EBIT / Enterprise Value of 6.7% ranks as Above Average.|
|The Free Cash Flow / Enterprise Value of 4.1% ranks as Average.|
|The Return on Invested Capital Value of 18.5% ranks as Above Average.|
|The Cash Return on Capital Value of 10.7% ranks as Average.|
|The 3 Year Average Revenue Growth Value of 6.6% ranks as Average.|
|Near-term Financial Health appears to be Very Good. The Current Ratio is 1.55.|
Henry Schein, Inc. engages in the provision of providing health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following business segments: Healthcare Distribution, and Technology & Value-Added Services. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
|Cognex Corporation (CGNX)|
|iRobot Corporation (IRBT)|
|Target Corporation (TGT)|
|Buckle, Inc. (BKE)|
|Talend SA Sponsored ADR (TLND)|